Securities Code: 002332
Securities Abbreviation: Xianju Pharmaceutical
Announcement Number: 2026-044
Zhejiang Xianju Pharmaceutical Co., Ltd.
Announcement on the Results of the Company's Share Repurchase and Changes in Share Capital
The Company and all members of the Board of Directors guarantee the truthfulness, accuracy, and completeness of the information disclosed, and are free from any false records, misleading statements, or material omissions.
Zhejiang Xianju Pharmaceutical Co., Ltd. (hereinafter referred to as the "Company") held the fourth (extraordinary) meeting of the ninth Board of Directors on May 14, 2026, and deliberated and approved the "Proposal on the Share Repurchase Plan." The Company agreed to use RMB 80 million (inclusive) to RMB 150 million (inclusive) to repurchase a portion of its issued RMB ordinary shares (A shares) through centralized bidding transactions. The repurchased shares are intended for the Company's equity incentives or employee stock ownership plans. The funds for the repurchase will come from the Company's own funds and raised funds. The repurchase price will not exceed RMB 13.45 per share (inclusive). The implementation period for this share repurchase will be within 12 months from the date the Board of Directors approved the share repurchase plan.
Following the implementation of the Company's 2025 equity distribution, in accordance with the relevant regulations of the China Securities Regulatory Commission and the Shenzhen Stock Exchange, the upper limit for the share repurchase price should be adjusted. The upper limit for the repurchase price in the Company's aforementioned repurchase plan has been adjusted from not exceeding RMB 13.45 per share (inclusive) to not exceeding RMB 13.25 per share (inclusive).
For specific details, please refer to the "Announcement on the Company's Share Repurchase Plan" (Announcement No.: 2026-023), "Announcement on the Implementation of the 2025 Annual Equity Distribution" (Announcement No.: 2026-028), "Announcement on the Adjustment of the Upper Limit of the Share Repurchase Price after the Implementation of the 2025 Annual Equity Distribution" (Announcement No.: 2026-030), and "Repurchase Report on Repurchasing Shares through Centralized Bidding Transactions" (Announcement No.: 2026-033) disclosed by the Company on May 15, 2026, May 22, 2026, May 29, 2026, and June 10, 2026, in Securities Times, China Securities Journal, Shanghai Securities News, Securities Daily, and the Juchao Information Network (http://www.cninfo.com.cn).